日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Corrigendum to "Adjuvant immunotherapy in the modern management of resectable melanoma: current status and outlook to 2028": [ESMO Open 10 (2025) 104295]

对“可切除黑色素瘤现代治疗中的辅助免疫疗法:现状及2028年展望”的更正:[ESMO Open 10 (2025) 104295]

Donia, M; Jespersen, H; Jalving, M; Lee, R; Eriksson, H; Hoeller, C; Hernberg, M; Gavrilova, I; Kandolf, L; Liszkay, G; Helgadottir, H; Zhukavets, A; Pjanova, D; Marquez-Rodas, I; Neyns, B; Westgeest, H; Pourmir, I; Sobczuk, P; Ellebaek, E; Amaral, T

Adjuvant immunotherapy in the modern management of resectable melanoma: current status and outlook to 2028

可切除黑色素瘤现代治疗中的辅助免疫疗法:现状及2028年展望

Donia, M; Jespersen, H; Jalving, M; Lee, R; Eriksson, H; Hoeller, C; Hernberg, M; Gavrilova, I; Kandolf, L; Liszkay, G; Helgadottir, H; Zhukavets, A; Pianova, D; Marquez-Rodas, I; Neyns, B; Westgeest, H; Pourmir, I; Sobczuk, P; Ellebaek, E; Amaral, T

A comparison of real-world data on adjuvant treatment in patients with stage III BRAF V600 mutated melanoma - Results of systematic literature research

对BRAF V600突变型III期黑色素瘤患者辅助治疗的真实世界数据进行比较——系统性文献研究结果

Amaral, Teresa; Nanz, Lena; Higuita, Lina Maria Serna; Ascierto, Paolo; Berking, Carola; Couselo, Eva Muñoz; Donia, Marco; Dummer, Reinhard; Gutzmer, Ralf; Haushild, Axel; Jalving, Mathilde; Lee, Rebecca; Lorigan, Paul; Marquez-Rodas, Ivan; Michelin, Olivier; Nathan, Paul; Robert, Caroline; Schadendorf, Dirk; Sobczuk, Pawel; Flatz, Lukas; Leiter, Ulrike; Garbe, Claus

Nomogram for predicting survival after first-line anti-PD-1-based immunotherapy in unresectable stage IV melanoma: a multicenter international study

用于预测不可切除的IV期黑色素瘤患者一线抗PD-1免疫疗法后生存期的列线图:一项多中心国际研究

Chatziioannou, E; Higuita, L M Serna; Kreft, S; Kandolf, L; Dujovic, B; Reinhardt, L; Tamara, E; Marquez-Rodas, I; Fortuna, A R F P; Nübling, A; Niessner, H; Forschner, A; Garbe, C; Popovic, A; Mirjana, B; Meier, F; Eigentler, T; Leiter, U; Flatz, L; Sinnberg, T; Amaral, T

Correlation between breast cancer subtypes determined by immunohistochemistry and n-COUNTER PAM50 assay: a real-world study

免疫组化和n-COUNTER PAM50检测确定的乳腺癌亚型之间的相关性:一项真实世界研究

Lopez-Tarruella, Sara; Del Monte-Millán, María; Roche-Molina, Marta; Jerez, Yolanda; Echavarria Diaz-Guardamino, Isabel; Herrero López, Blanca; Gamez Casado, Salvador; Marquez-Rodas, Iván; Alvarez, Enrique; Cebollero, María; Massarrah, Tatiana; Ocaña, Inmaculada; Arias, Ainhoa; García-Sáenz, José Ángel; Moreno Anton, Fernando; Olier Garate, Clara; Moreno Muñoz, Diana; Marrupe, David; Lara Álvarez, Miguel Ángel; Enrech, Santos; Bueno Muiño, Coralia; Martín, Miguel

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III/IV Melanoma: 5-Year Efficacy and Biomarker Results from CheckMate 238

辅助治疗中,纳武利尤单抗与伊匹木单抗在切除的 III/IV 期黑色素瘤中的比较:CheckMate 238 研究的 5 年疗效和生物标志物结果

Larkin, James; Del Vecchio, Michele; Mandalá, Mario; Gogas, Helen; Arance Fernandez, Ana M; Dalle, Stéphane; Cowey, Charles Lance; Schenker, Michael; Grob, Jean-Jacques; Chiarion-Sileni, Vanna; Marquez-Rodas, Ivan; Butler, Marcus O; Di Giacomo, Anna Maria; Middleton, Mark R; Lutzky, Jose; de la Cruz-Merino, Luis; Arenberger, Petr; Atkinson, Victoria; Hill, Andrew G; Fecher, Leslie A; Millward, Michael; Nathan, Paul D; Khushalani, Nikhil I; Queirolo, Paola; Ritchings, Corey; Lobo, Maurice; Askelson, Margarita; Tang, Hao; Dolfi, Sonia; Ascierto, Paolo A; Weber, Jeffrey

COVID-19 in melanoma patients: Results of the Spanish Melanoma Group Registry, GRAVID study

黑色素瘤患者中的 COVID-19:西班牙黑色素瘤组登记处 GRAVID 研究的结果

Gonzalez-Cao, Maria; Carrera, Cristina; Rodriguez Moreno, Juan Francisco; Rodríguez-Jiménez, Pedro; Basa, Mónica Antoñanzas; Ochoa, Rosa Feltes; Puertolas, Teresa; Muñoz-Couselo, Eva; Manzano, José Luis; Marquez-Rodas, Ivan; Martín-Liberal, Juan; Soria, Ainara; Criado, Pilar Lopez; Garcia-Castaño, Almudena; Boada, Aram; Ayala de Miguel, Pablo; Puig, Susana; Crespo, Guillermo; Fra, Pablo Luna; Zamora, Cristina Aguayo; Rodríguez, Marta Feito; Valles, Lara; Drozdowskyj, Ana; Maldonado-Seral, Cayetana; Gardeazabal, Jesús; Villalobos, Laura; Rosell, Rafael; Fernandez-Morales, Luis Antonio; Rodrigo, Alberto; Viteri, Santiago; Provencio, Mariano; Berrocal, Alfonso

Adjuvant nivolumab for stage III/IV melanoma: evaluation of safety outcomes and association with recurrence-free survival

辅助性纳武利尤单抗治疗III/IV期黑色素瘤:安全性结果评估及其与无复发生存期的关系

Mandala, Mario; Larkin, James; Ascierto, Paolo Antonio; Del Vecchio, Michele; Gogas, Helen; Cowey, C Lance; Arance, Ana; Dalle, Stéphane; Schenker, Michael; Grob, Jean-Jacques; Chiarion-Sileni, Vanna; Marquez-Rodas, Ivan; Butler, Marcus O; Di Giacomo, Anna Maria; Lutzky, Jose; De La Cruz-Merino, Luis; Atkinson, Victoria; Arenberger, Petr; Hill, Andrew; Fecher, Leslie; Millward, Michael; Khushalani, Nikhil I; de Pril, Veerle; Lobo, Maurice; Weber, Jeffrey

Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenografts

多西他赛、卡铂和阿霉素在患者来源的三阴性乳腺癌异种移植模型中的活性

Martin, Miguel; Ramos-Medina, Rocio; Bernat, Rebeca; García-Saenz, Jose Angel; Del Monte-Millan, Maria; Alvarez, Enrique; Cebollero, Maria; Moreno, Fernando; Gonzalez-Haba, Eva; Bueno, Oscar; Romero, Paula; Massarrah, Tatiana; Echavarria, Isabel; Jerez, Yolanda; Herrero, Blanca; Gonzalez Del Val, Ricardo; Lobato, Nerea; Rincon, Patricia; Palomero, Maria Isabel; Marquez-Rodas, Ivan; Lizarraga, Santiago; Asensio, Fernando; Lopez-Tarruella, Sara

Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma: Results From the Phase IIIb/IV CheckMate 511 Trial

评估两种纳武利尤单抗联合伊匹木单抗治疗晚期黑色素瘤患者的给药方案:来自 IIIb/IV 期 CheckMate 511 试验的结果

Lebbé, Celeste; Meyer, Nicolas; Mortier, Laurent; Marquez-Rodas, Ivan; Robert, Caroline; Rutkowski, Piotr; Menzies, Alexander M; Eigentler, Thomas; Ascierto, Paolo A; Smylie, Michael; Schadendorf, Dirk; Ajaz, Mazhar; Svane, Inge Marie; Gonzalez, Rene; Rollin, Linda; Lord-Bessen, Jennifer; Saci, Abdel; Grigoryeva, Elena; Pigozzo, Jacopo